BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 31233623)

  • 1. Severity and Area Score for Hidradenitis (SASH): a novel outcome measurement for hidradenitis suppurativa.
    Kirby JS; Butt M; King T
    Br J Dermatol; 2020 Apr; 182(4):940-948. PubMed ID: 31233623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
    Thorlacius L; Garg A; Riis PT; Nielsen SM; Bettoli V; Ingram JR; Del Marmol V; Matusiak L; Pascual JC; Revuz J; Sartorius K; Tzellos T; van der Zee HH; Zouboulis CC; Saunte DM; Gottlieb AB; Christensen R; Jemec GBE
    Br J Dermatol; 2019 Sep; 181(3):483-491. PubMed ID: 30724351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could Residents Adequately Assess the Severity of Hidradenitis Suppurativa? Interrater and Intrarater Reliability Assessment of Major Scoring Systems.
    Włodarek K; Stefaniak A; Matusiak Ł; Szepietowski JC
    Dermatology; 2020; 236(1):8-14. PubMed ID: 31487719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hidradenitis Suppurativa Area and Severity Index Revised (HASI-R): psychometric property assessment.
    Goldfarb N; Lowes MA; Butt M; King T; Alavi A; Kirby JS
    Br J Dermatol; 2021 May; 184(5):905-912. PubMed ID: 32969027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of the hidradenitis suppurativa clinical response in the assessment of patients with hidradenitis suppurativa.
    Kimball AB; Ganguli A; Fleischer A
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2254-2256. PubMed ID: 29959796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of global item for assessing impact on quality of life of patients with hidradenitis suppurativa.
    Kirby JS; Hereford B; Thorlacius L; Villumsen B; Ingram JR; Garg A; Butt M; Esmann S; King T; Tan J; Jemec GBE
    Br J Dermatol; 2021 Apr; 184(4):681-687. PubMed ID: 32602129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inter- and intrarater reliability of Hurley staging for hidradenitis suppurativa.
    Ovadja ZN; Schuit MM; van der Horst CMAM; Lapid O
    Br J Dermatol; 2019 Aug; 181(2):344-349. PubMed ID: 30585304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment.
    Kimball AB; Jemec GB; Yang M; Kageleiry A; Signorovitch JE; Okun MM; Gu Y; Wang K; Mulani P; Sundaram M
    Br J Dermatol; 2014 Dec; 171(6):1434-42. PubMed ID: 25040429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Hidradenitis Suppurativa Investigator Global Assessment: A Novel Hidradenitis Suppurativa-Specific Investigator Global Assessment for Use in Interventional Trials.
    Garg A; Zema C; Ciaravino V; Rolleri R; Peterson L; Garcia L; Massaro T; Jemec GBE; Kirby JS; Thorlacius L; Ingram JR
    JAMA Dermatol; 2023 Jun; 159(6):606-612. PubMed ID: 37099284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inter-rater reliability of phenotypes and exploratory genotype-phenotype analysis in inherited hidradenitis suppurativa.
    Frew JW; Hawkes JE; Sullivan-Whalen M; Gilleaudeau P; Krueger JG
    Br J Dermatol; 2019 Sep; 181(3):566-571. PubMed ID: 30693478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of inter-rater reliability of clinical hidradenitis suppurativa outcome measures using ultrasonography.
    Lyons AB; Narla S; Kohli I; Zubair R; Nahhas AF; Braunberger TL; Joseph MK; Nicholson CL; Jacobsen G; Hamzavi IH
    Clin Exp Dermatol; 2022 Feb; 47(2):319-324. PubMed ID: 34388853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials.
    Kirby JS; Thorlacius L; Villumsen B; Ingram JR; Garg A; Christensen KB; Butt M; Esmann S; Tan J; Jemec GBE
    Br J Dermatol; 2020 Aug; 183(2):340-348. PubMed ID: 31705538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and initial validation of the HS-IGA: a novel hidradenitis suppurativa-specific investigator global assessment for use in interventional trials.
    Garg A; Zema C; Kim K; Gao W; Chen N; Jemec GBE; Kirby J; Thorlacius L; Villumsen B; Ingram JR
    Br J Dermatol; 2022 Aug; 187(2):203-210. PubMed ID: 35599448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electronic Patient-Reported Outcomes in Hidradenitis Suppurativa: Content Validity and Usability of the Electronic Hidradenitis Suppurativa Symptom Daily Diary, Hidradenitis Suppurativa Symptom Questionnaire, and Hidradenitis Suppurativa Quality of Life Questionnaire.
    Ingram JR; Ciaravino V; Rolleri R; Pansar I; Dias-Barbosa C; Kirby JS
    Dermatology; 2024; 240(1):65-76. PubMed ID: 37820596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa.
    Peris K; Lo Schiavo A; Fabbrocini G; Dini V; Patrizi A; Fusano M; Bianchi L; Guanziroli E; Guarneri C; Parodi A; Bertoldi A; Musumeci ML; Offidani A; Rongioletti F; Pistone G; Malara G; Potenza C; Casari A; Franchi C; Ardigò M; Cusano F; Stingeni L; Amerio P; Mancini LL; Prignano F; Deboli T; Gualberti G; Saragaglia V; Bettoli V
    J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):766-773. PubMed ID: 30633405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The reliability of three psoriasis assessment tools: Psoriasis area and severity index, body surface area and physician global assessment.
    Bożek A; Reich A
    Adv Clin Exp Med; 2017 Aug; 26(5):851-856. PubMed ID: 29068583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Severity Assessment Scoring System for Hidradenitis Suppurativa.
    Hessam S; Scholl L; Sand M; Schmitz L; Reitenbach S; Bechara FG
    JAMA Dermatol; 2018 Mar; 154(3):330-335. PubMed ID: 29417136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot comparison study of four clinician-rated atopic dermatitis severity scales.
    Zhao CY; Tran AQ; Lazo-Dizon JP; Kim J; Daniel BS; Venugopal SS; Rhodes LM; Law MG; Murrell DF
    Br J Dermatol; 2015 Aug; 173(2):488-97. PubMed ID: 25891151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability and convergent validity of the cutaneous sarcoidosis activity and morphology instrument for assessing cutaneous sarcoidosis.
    Rosenbach M; Yeung H; Chu EY; Kim EJ; Payne AS; Takeshita J; Vittorio CC; Wanat KA; Werth VP; Gelfand JM
    JAMA Dermatol; 2013 May; 149(5):550-6. PubMed ID: 23677081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automatic International Hidradenitis Suppurativa Severity Score System (AIHS4): A novel tool to assess the severity of hidradenitis suppurativa using artificial intelligence.
    Hernández Montilla I; Medela A; Mac Carthy T; Aguilar A; Gómez Tejerina P; Vilas Sueiro A; González Pérez AM; Vergara de la Campa L; Luna Bastante L; García Castro R; Alfageme Roldán F
    Skin Res Technol; 2023 Jun; 29(6):e13357. PubMed ID: 37357665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.